ESC 365 - Controversies in cell therapies for myocardial infarction and heart failure

Open Access

Controversies in cell therapies for myocardial infarction and heart failure

Event: Frontiers in CardioVascular Biology 2018

Topic: Cardiac Diseases

Session type: Symposium

Date: 20 April 2018

Time: 17:00 - 18:30

Session

4 presentations in this session

Induced pluripotent stem cells (iPSCs) and their potential in regenerative medicine - PRO

Speaker: Professor J. Dulak (Krakow, PL)

Cell therapy for heart disease: unmet expectations - CON

Speaker: Professor P. Menasche (Paris, FR)

Cell based therapies for myocardial repair and regeneration in ischaemic heart disease and heart failure - PRO

Speaker: Assistant Professor R. Madonna (Pisa, IT)

What we can learn from meta-analysis of the clinical trials of cell therapy - CON

Speaker: Professor M. Gyongyosi (Vienna, AT)

4 speakers from this session

Professor Jozef Dulak

Jagiellonian University, Krakow (Poland)

3 presentations

0 follower

Professor Philippe Menasche

Hopital Europeen Georges Pompidou- University Paris Descartes, Paris (France)

8 presentations

0 follower

Assistant Professor Rosalinda Madonna

University of Pisa, Pisa (Italy)

5 presentations

0 follower

Professor Mariann Gyongyosi

Medical University of Vienna, Vienna (Austria)

3 presentations

0 follower

This platform is supported by